President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the prices of medication abroad, sources told CBS News.

On May 12, 2025, President Donald Trump signed the executive order (EO) “ Delivering Most-Favored-Nation Prescription Drug Pricing To American Patients .” The EO sets forth policy positions that attempt to further reign in drug prices beyond the scope of drug price negotiation under the Inflation Reduction Act (IRA).

President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit managers, commonly known as PBMs.

President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the pharmaceutical industry before he’s even signed an executive order he says will lower

An executive order from President Trump aims to make deep cuts to prescription drug costs, putting GOP lawmakers who have traditionally opposed government-directed drug pricing in a tough position.

The White House has set a one-month deadline for drug manufacturers to negotiate lower prices. If they fail to do so, the administration plans to implement “most-favored nation”